Over 4 mln COVID-19 vaccine doses from China's CNBG administered in emergency use - (National Post via NewsPoints Desk)

  • Sinopharm's China National Biotec Group (CNBG) has administered more than 4 million COVID-19 vaccine doses as of January 4 via China's emergency use program, as reported in the National Post.

  • Two vaccines respectively from two institutes owned by CNBG are included in China’s emergency vaccination scheme, which was officially started in July targeting specific groups of people facing a high infection risk.

  • "No serious adverse reaction was reported in large-scale emergency use of Sinopharm's COVID-19 vaccines," CNBG said.

  • The company noted that a total of 72,000 people have been overseas after receiving China's emergency jabs, including around 40% of more than 5000 staffers on one Chinese firm's Pakistan-based project.

To read more NewsPoints articles, click here.